中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2011年
1期
47-49
,共3页
林海%王权光%张慧玲%刘乐%皮治兵%徐旭仲
林海%王權光%張慧玲%劉樂%皮治兵%徐旭仲
림해%왕권광%장혜령%류악%피치병%서욱중
神经传导阻滞%肋间神经%超声检查%疱疹,带状%神经痛
神經傳導阻滯%肋間神經%超聲檢查%皰疹,帶狀%神經痛
신경전도조체%륵간신경%초성검사%포진,대상%신경통
Nerve block%Intercostal nerves%Ultrasonography%Herpes zoster%Neuralgia
目的 评价超声引导后路肋间神经阻滞对带状疱疹性神经痛患者的疗效.方法 拟行后路肋间神经阻滞的胸背部带状疱疹性神经痛患者48例,性别不限,年龄56~84岁,体重48~83 kg病程<30 d.后路肋间神经阻滞用药:0.75%罗哌卡因10ml+确炎舒松A 20 mg+2%亚甲蓝2ml,用0.9%生理盐水配制成20ml.采用便携超声仪和高频直线探头(6~13 MHz)或腹部扇形探头(2~5 MHz),采用超声引导长轴平面内技术,穿刺针尖到达胸膜外,近肋骨下阴影区域时,回吸注射器无回血后,根据带状疱疹分布阻滞肋间神经,每束肋间神经注射镇痛药3ml.于治疗前、治疗后1、2、4和8周采用VAS评分法评价疼痛程度,计算疼痛缓解度,采用生活质量评分法评价生活质量;于治疗后8周进行镇痛疗效分级,计算治疗有效率和显效率,记录并发症的发生情况.结果 操作过程中均未发生穿刺针误穿胸膜,阻滞后患者均未发生胸闷或呼吸困难.治疗后各时点VAS评分降低,生活质量升高,疼痛缓解度逐渐升高(P<0.05或0.01).治疗后8周有效率96%,显效率83%.结论 超声引导后路肋间神经阻滞对带状疱疹性神经痛患者的疗效确切,不良反应少,改善了生活质量.
目的 評價超聲引導後路肋間神經阻滯對帶狀皰疹性神經痛患者的療效.方法 擬行後路肋間神經阻滯的胸揹部帶狀皰疹性神經痛患者48例,性彆不限,年齡56~84歲,體重48~83 kg病程<30 d.後路肋間神經阻滯用藥:0.75%囉哌卡因10ml+確炎舒鬆A 20 mg+2%亞甲藍2ml,用0.9%生理鹽水配製成20ml.採用便攜超聲儀和高頻直線探頭(6~13 MHz)或腹部扇形探頭(2~5 MHz),採用超聲引導長軸平麵內技術,穿刺針尖到達胸膜外,近肋骨下陰影區域時,迴吸註射器無迴血後,根據帶狀皰疹分佈阻滯肋間神經,每束肋間神經註射鎮痛藥3ml.于治療前、治療後1、2、4和8週採用VAS評分法評價疼痛程度,計算疼痛緩解度,採用生活質量評分法評價生活質量;于治療後8週進行鎮痛療效分級,計算治療有效率和顯效率,記錄併髮癥的髮生情況.結果 操作過程中均未髮生穿刺針誤穿胸膜,阻滯後患者均未髮生胸悶或呼吸睏難.治療後各時點VAS評分降低,生活質量升高,疼痛緩解度逐漸升高(P<0.05或0.01).治療後8週有效率96%,顯效率83%.結論 超聲引導後路肋間神經阻滯對帶狀皰疹性神經痛患者的療效確切,不良反應少,改善瞭生活質量.
목적 평개초성인도후로륵간신경조체대대상포진성신경통환자적료효.방법 의행후로륵간신경조체적흉배부대상포진성신경통환자48례,성별불한,년령56~84세,체중48~83 kg병정<30 d.후로륵간신경조체용약:0.75%라고잡인10ml+학염서송A 20 mg+2%아갑람2ml,용0.9%생리염수배제성20ml.채용편휴초성의화고빈직선탐두(6~13 MHz)혹복부선형탐두(2~5 MHz),채용초성인도장축평면내기술,천자침첨도체흉막외,근륵골하음영구역시,회흡주사기무회혈후,근거대상포진분포조체륵간신경,매속륵간신경주사진통약3ml.우치료전、치료후1、2、4화8주채용VAS평분법평개동통정도,계산동통완해도,채용생활질량평분법평개생활질량;우치료후8주진행진통료효분급,계산치료유효솔화현효솔,기록병발증적발생정황.결과 조작과정중균미발생천자침오천흉막,조체후환자균미발생흉민혹호흡곤난.치료후각시점VAS평분강저,생활질량승고,동통완해도축점승고(P<0.05혹0.01).치료후8주유효솔96%,현효솔83%.결론 초성인도후로륵간신경조체대대상포진성신경통환자적료효학절,불량반응소,개선료생활질량.
Objective To evaluate ultrasound-guided posterior approach to intercostal block for herpetic neuralgia. Methods Forty-eight patients with herpetic neuralgia after appearance of rashes on the back of chest (the coursc < 30 days) aged 56-84 yr received intercostal block performed via posterior approach under the guidance of ultrasound with a mixture of 0.75% ropivacaine, glucocorticoid and methylene blue. Pain was assessed with visual analogue scale (VAS) before block and at 1, 2, 4 and 8 weeks after block. Pain relief (PAR) was cal-culated (PAR= (VAS score before block- VAS score after block) ÷ VAS score before block × 100%). Results No patient developed dyspnea and pneumothorax. VAS scores were reduced significantly, quality of life was improved and PAR increased at 1, 2, 4 ancl 8 weeks after block ( P < 0.05 or 0.01). Concluslon Ultracound-guided posterior approach to intercostal block is safe and effective for the treatment of herpetic neuralgia.